[ET Net News Agency, 10 November 2023] UBS raised its price target for CanSino Bio
(06185) to HKD38 from HKD36 and upgraded its rating to "buy" from "neutral".
The research house said it cuts 2023E EPS as it includes the revenue reversal of RMB239m
and lowers 2024E net income as it forecasts higher selling expenses.
It lifts 2025E EPS 3% on higher MCV sales revenue and GPM. (RC)